LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Woodline Partners LP's Holding History (CIK: 0001784547)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 20,740 Value ($000) $30 Avg Close — Range —
Q1 2024
Shares 20,740 Value ($000) $46 Avg Close — Range —
Q4 2023
Shares 20,740 Value ($000) $40 Avg Close — Range —
Q3 2023
Shares 20,740 Value ($000) $30 Avg Close — Range —
Q2 2023
Shares 20,740 Value ($000) $66 Avg Close — Range —
Q1 2023
Shares 20,740 Value ($000) $49 Avg Close — Range —
Q4 2022
Shares 20,740 Value ($000) $72 Avg Close — Range —
Q3 2022
Shares 20,740 Value ($000) $152 Avg Close — Range —
Q1 2022
Shares 201,793 Value ($000) $1,019 Avg Close — Range —
Q4 2021
Shares 201,793 Value ($000) $1,562 Avg Close — Range —
Q3 2021
Shares 205,870 Value ($000) $3,047 Avg Close — Range —
Q2 2021
Shares 499,559 Value ($000) $8,113 Avg Close — Range —